Remedor Biomed

A clinical research stage biopharmaceutical company focused on revolutionizing complex wound treatment through patented technology.

Health Tech & Life Sciences
Active
Mature Nof HaGalil, Israel Founded 2009
Last updated 2026-07-23
Total raised
Last: Grant 2009-12
Stage
Mature
Founded
2009
Headcount
6
HQ
Nof HaGalil, Israel
Sector
Health Tech & Life Sciences

About

Remedor Biomed is a clinical research stage biopharmaceutical company that develops innovative topical formulations for tissue regeneration, focusing on diabetic foot ulcers, complex skin wound conditions, and severe burns. The company's lead product, WOUNDAGEL™, is a topical hydrogel-based therapy designed to accelerate the healing of chronic and acute skin wounds. Remedor Biomed aims to provide safe and cost-effective pharmaceutical solutions to improve patients' quality of life. The company's technology platform is based on a formulation containing erythropoietin (EPO), a naturally occurring glycoprotein, which is active in each phase of the healing process.

Funding history · 1 round · — total

2009-11
Grant Undisclosed

Headcount over time

From 5 (2019-03) to 11 (2026-07) · +6 (+120%) · 5 points · source: Finder history + radar grounding
110 2019-03 2026-07

Q&A

What is Remedor Biomed's primary focus?
Remedor Biomed is a clinical research stage biopharmaceutical company focused on developing medications for skin wounds that do not respond well to current treatment options, specifically complex wounds like diabetic foot ulcers and deep burn wounds.
What is the core technology behind Remedor Biomed's medications?
Remedor Biomed's technology platform is based on a formulation containing erythropoietin, a naturally occurring glycoprotein, delivered via a proprietary topical biologic technology platform using a smart hydrogel-matrix.
When was Remedor Biomed founded?
Remedor Biomed was founded in November 2009.
Where is Remedor Biomed headquartered?
Remedor Biomed is headquartered in Nof HaGalil, Israel.
How many employees does Remedor Biomed have?
Remedor Biomed has 1-10 employees.
Has Remedor Biomed received any funding?
In December 2009, Remedor Biomed received a Grant from Israel Innovation Authority.
Who is the founder and CEO of Remedor Biomed?
Saher Hamed, M.D., Ph.D. is the Founder & CEO of Remedor Biomed.
What is Remedor Biomed's primary sector?
Remedor Biomed's primary sector is Health Tech & Life Sciences.

Team · 1

Saher Hamed
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B

Highlights

1 PatentsVerified

Tags

ulcerstissue-regenerationregenerative-medicinediabetestopical-treatmentbiopharmaceuticalpharmaceuticalschronic-patientspharma-companiestype-2-diabetes
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteremedor.com/
LinkedInlinkedin.com/company/9166050
Facebookfacebook.com/remedorbiomed

Identifiers & details

Legal nameRemedor Biomed Ltd.
Founded2009-11
Employees (exact)6

Radar intelligence

Patents

EPO6

Web history (Wayback)

Domainremedor.com

Certificate / subdomain footprint

Subdomains7

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514361310
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2009-12-14
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events4 — shares_capital (3), other (1)
Registered addressהעבודה 12 נוף הגליל

Recent registry events

DateEvent
2026-06-29הגדלה של הון רשום
2026-06-29הקצאת מניות
2026-06-25שינוי בהרכב הון - מניות-הפחתת הון מוקצה
2026-07-02שינוי בתקנון